vigilneuro.com - Wutah dodolan YoY (TTM) VIGL

The TTM revenue growth rate compared to the same period last year on the GURU.Markets chart demonstrates a trend where 0.00 shows the current value of the metric. Vigil Neuroscience (VIGL) develops drugs for rare brain pathologies in Massachusetts using immunological activation of neurons. The production of biological substances is outsourced to external CMO facilities in the US and Europe, while clinical trials are implemented through a network of contract research organizations.
Vigil Neuroscience (VIGL) - rincian metrik lan laporan keuangan

Fundamental asset selection is based on an analysis of business scaling rates via revenue dynamics over the last twelve months. This indicator measures the daily change in total income, reflecting market demand for Vigil Neuroscience (VIGL) innovative microglia therapy drugs, which allows for an assessment of the commercial potential in combating Alzheimer's disease based on the trailing twelve months (TTM) growth in operating sales revenue.